{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:32:08Z","timestamp":1794709928000,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.seizure.2026.03.015","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:57:24Z","timestamp":1774630644000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Early antiseizure medication tapering in 2\u201318-year-olds with single parenchymal neurocysticercosis based on risk assessment: A prospective intervention study"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3600-5308","authenticated-orcid":false,"given":"P","family":"Ghanghoriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-7386","authenticated-orcid":false,"given":"B","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Jauhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RM","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AD","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2026.03.015_bib0001","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.eplepsyres.2014.04.013","article-title":"Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis","volume":"108","author":"Gulati","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2026.03.015_bib0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.seizure.2020.10.012","article-title":"A prospective cohort study to assess the frequency and risk factors for calcification in single lesion parenchymal neurocysticercosis","volume":"83","author":"Suthar","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2026.03.015_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pediatrneurol.2023.11.006","article-title":"Incident breakthrough seizures, serum matrix metalloproteinase-9 and perfusion magnetic resonance imaging parameters in a cohort of children and adolescents with neurocysticercosis: a longitudinal observational study","volume":"151","author":"Chakrabarty","year":"2024","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2026.03.015_bib0004","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.seizure.2013.07.001","article-title":"Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation","volume":"22","author":"Sharma","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2026.03.015_bib0005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1474-4422(08)70243-6","article-title":"Cysticercosis Working Group in Peru. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study","volume":"7","author":"Nash","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2026.03.015_bib0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eplepsyres.2017.09.010","article-title":"Clinical and neuroimaging predictors of seizure recurrence in solitary calcified neurocysticercosis: a prospective observational study","volume":"137","author":"Singh","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2026.03.015_bib0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/ANT.33-4_112_0052","article-title":"Clinical characteristics and risk factors for seizures to recur in calcified neurocysticercosis: prospective cohort study","volume":"33","author":"Verma","year":"2024","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.seizure.2026.03.015_bib0008","doi-asserted-by":"crossref","first-page":"e3288","DOI":"10.1097\/MD.0000000000003288","article-title":"Toll-like receptor-4 polymorphisms and serum matrix metalloproteinase-9 in newly diagnosed patients with calcified neurocysticercosis and seizures","volume":"95","author":"Lachuriya","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.seizure.2026.03.015_bib0009","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14581\/jer.21018","article-title":"Predictors of seizure recurrence in solitary calcified neurocysticercosis in relation to computed tomography scan: prospective observational study","volume":"11","author":"Singla","year":"2021","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.seizure.2026.03.015_bib0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4269\/ajtmh.19-0278","article-title":"An ambispective cohort study to assess seizure recurrences in children with calcified parenchymal neurocysticercosis","volume":"101","author":"Modak","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.seizure.2026.03.015_bib0011","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/tropej\/49.5.274","article-title":"One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions","volume":"49","author":"Singhi","year":"2003","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.seizure.2026.03.015_bib0012","first-page":"141","article-title":"Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?","volume":"50","author":"Thussu","year":"2002","journal-title":"Neurol India"},{"key":"10.1016\/j.seizure.2026.03.015_bib0013","first-page":"145","article-title":"Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain","volume":"50","author":"Gupta","year":"2002","journal-title":"Neurol India"},{"key":"10.1016\/j.seizure.2026.03.015_bib0014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0404.2005.00538.x","article-title":"Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma","volume":"113","author":"Verma","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2026.03.015_bib0015","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1212\/WNL.44.9.1706","article-title":"Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis","volume":"44","author":"Del Brutto","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.03.015_bib0016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0404.2009.01180.x","article-title":"Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India","volume":"121","author":"Goel","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2026.03.015_bib0017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2310\/7010.2001.7057","article-title":"Seizure recurrence in children with focal seizures and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up","volume":"16","author":"Baranwal","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2026.03.015_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009193","article-title":"The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: a meta-analysis and expert group-based consensus recommendations","volume":"15","author":"Abraham","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.seizure.2026.03.015_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mri.2018.01.001","article-title":"Dynamic contrast-enhanced (DCE) MRI derived kinetic perfusion indices may help predicting seizure control in single calcified neurocysticercosis","volume":"49","author":"Singh","year":"2018","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.seizure.2026.03.015_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yebeh.2014.12.015","article-title":"Calcified parenchymal central nervous system cysticercosis and clinical outcomes in epilepsy","volume":"43","author":"Leon","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2026.03.015_bib0021","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4269\/ajtmh.14-0453","article-title":"Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study","volume":"92","author":"Del Brutto","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.seizure.2026.03.015_bib0022","article-title":"Antiepileptic drugs for seizure control in people with neurocysticercosis","volume":"10","author":"Frackowiak","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2026.03.015_bib0023","article-title":"Antiepileptic drugs for seizure control in people with neurocysticercosis","volume":"11","author":"Walton","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2026.03.015_bib0024","article-title":"Antiepileptic drugs for seizure control in people with neurocysticercosis","volume":"10","author":"Sharma","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2026.03.015_bib0025","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/cid\/cix1084","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"66","author":"Jr","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.seizure.2026.03.015_bib0026","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2026.03.015_bib0027","series-title":"Cysticercosis of the central nervous system","first-page":"27","article-title":"The pathology of neurocysticercosis","author":"Escobar","year":"1983"},{"key":"10.1016\/j.seizure.2026.03.015_bib0028","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1528-1157.1999.tb01607.x","article-title":"The association between seizure clustering and convulsive status epilepticus in patients with intractable complex partial seizures","volume":"40","author":"Haut","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.03.015_bib0029","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.WNL.0000130471.19171.D8","article-title":"Seizure outcome in patients with a solitary cerebral cysticercus granuloma","volume":"62","author":"Rajshekhar","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.03.015_bib0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2009.09.018","article-title":"Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution","volume":"28","author":"De Souza","year":"2010","journal-title":"J Neurol Sci"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:22:03Z","timestamp":1778797323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"alternative-id":["S1059131126000804"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.03.015","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early antiseizure medication tapering in 2\u201318-year-olds with single parenchymal neurocysticercosis based on risk assessment: A prospective intervention study","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}